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Myocarditis is an inflammatory disease caused by viral infection. Different subpopulations of leukocytes enter the cardiac tissue
and lead to severe cardiac inflammation associated with myocyte loss and remodeling. Here, we study possible cell sources for
viral replication using three compartments of the heart: fibroblasts, cardiomyocytes, and macrophages. We infected C57BL/6j mice
with Coxsackievirus B3 (CVB3) and detected increased gene expression of anti-inflammatory and antiviral cytokines in the heart.
Subsequently, we infected cardiac fibroblasts, cardiomyocytes, andmacrophageswithCVB3.Due to viral infection, the expression of
TNF-𝛼, IL-6,MCP-1, and IFN-𝛽was significantly increased in cardiac fibroblasts compared to cardiomyocytes ormacrophages.We
found that in addition to cardiomyocytes cardiac fibroblastswere infected byCVB3 anddisplayed a higher virus replication (132-fold
increase) compared to cardiomyocytes (14-fold increase) between 6 and 24 hours after infection. At higher virus concentrations,
macrophages are able to reduce the viral copy number. At low virus concentration a persistent virus infection was determined.
Therefore, we suggest that cardiac fibroblasts play an important role in the pathology of CVB3-inducedmyocarditis and are another
important contributor of virus replication aggravating myocarditis.
1. Introduction
Myocarditis is an inflammatory disease of the heart muscle
often resulting in cardiac dysfunction and death, especially
in young patients [1, 2]. The gold standard for diagnosing
myocarditis is based on histopathology from endomyocardial
biopsies, in which clear inflammatory cellular infiltrates are
present [1, 3–5].
One of the most common causes for acute myocarditis is
a cardiac infection with viruses, especially with enteroviruses
of the Coxsackievirus B family [1, 6, 7]. This virus-induced
myocarditis remains still one major cause of dilated car-
diomyopathy. Virus-mediated cell lysis leads to destruction
of cardiac cells, especially cardiomyocytes. The destroyed
cardiomyocytes are then replaced by fibrosis which finally
may lead to dilated cardiomyopathy.
CVB3-induced viral myocarditis is a well-established
model to elucidate viral myocarditis in mice [8–14]. In this
model, mice were infected intraperitoneally with CVB3 and
within a few days a severe inflammation and virus replication
can be observed in the cardiac tissue. In general, cells of the
innate immune system identify and engulf pathogens, which
are proteolytically processed and then presented as peptides
that are presented as antigens to cells of the adaptive immune
system [15, 16]. But it is known that those cells can also be
infected by virus suggesting that they may transport virus
particles into organs and infect resident cells [17]. Increased
gene expression of pro- and anti-inflammatory as well as
antiviral cytokines could be observed in infected cardiac
tissue [11–13, 18, 19]. But those cytokines can be expressed due
to the infiltration of inflammatory cells or due to activation of
resident cardiac cells triggered by viral infection [18–20].
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The infection of cardiomyocytes is well documented in
many publications [10, 13, 21, 22].Here, we compare the ability
of CVB3 to infect other cardiac cell types in addition to
cardiomyocytes, and we investigate the virus replication in
those cells.
In this study, we combined investigation in the experi-
mentally induced viral myocarditis in mice with cell culture
experiments of cardiac cells which were infected with CVB3.
Therefore, we used cardiac tissue fromCVB3-infectedmice to
evaluate the inflammatory immune response and compared
these results with the inflammatory immune response in the
cell culture system.Most studies focus on the virus replication
in cardiomyocytes and do not consider the cardiac fibroblasts
for virus replication [10, 21]. Our findings suggest that cardiac
fibroblasts initiate cardiac inflammation by increased expres-
sion of proinflammatory cytokines and further aggravate
viral myocarditis by higher virus replication compared to
cardiomyocytes. Interestingly, macrophages as part of the
innate immune system do not show high infection efficiency
and no complete virus clearance was observed.
2. Material and Methods
2.1. Study Design. Male C57BL/6j (B6) mice were used at an
age of 6 to 8 weeks. Animals were infected intraperitoneally
with 5 × 105 plaque forming units (pfu) of Coxsackievirus B3
(CVB3) (Nancy strain) diluted in PBS. As control subjects,
sham infections with PBS were performed. Five animals were
sham treated with PBS, whereas nine animals were infected
with CVB3. Seven days later CVB3-infected B6 mice were
hemodynamically characterized and compared to nonin-
fected healthy control mice (PBS treated). This investigation
conforms to the Guide for the Care and Use of Laboratory
Animals published by the US NIH (NIH Publication number
85-23, revised 1996).
2.2. Hemodynamic Measurements. For hemodynamic meas-
urements amicroconductance catheter (1.2F) system in open-
chest animals was used as described previously [23]. Animals
were anesthetized (0.8–1.2 g/kg urethane and 0.05mg/kg
buprenorphine i.p.) intubated and artificially ventilated. A
1.2F-microconductance pressure catheter (SciSense, Ontario,
Canada) was positioned in the left ventricle via the right
carotid artery for continuous registration of pressure-volume
loops. Global function was quantified by heart rate (bpm),
cardiac output (𝜇L/min), stroke volume (𝜇L), stroke work
(𝜇L × mmHg), and ejection fraction (%). Systolic function
was assessed by maximal pressure (𝑃max in mmHg), left
ventricular contractility (𝑑𝑃/𝑑𝑡max in mmHg/s), and end-
systolic volume (𝑉es in 𝜇L). Diastolic function was measured
by end-diastolic pressure (𝑃ed in mmHg), left ventricular
relaxation (𝑑𝑃/𝑑𝑡min in mmHg/s), left ventricular relaxation
time (Tau in ms), pressure halt time (PHT in ms), and end-
diastolic volume (𝑉ed in 𝜇L).
Hearts of sacrificed animals were removed and imme-
diately frozen in liquid nitrogen and stored at −80∘C for
later biomolecular analyses. For validation of inflammation
pieces of hearts were embedded in Tissue-Tek, sectioned, and
stained with hematoxylin and eosin.
2.3. RNA Isolation from Tissue Sections. Frozen tissue sec-
tions were minced in Trizol and further disrupted during
10min of vigorous shaking. To extract RNA, chloroform was
added, mixed, and centrifuged. The aqueous phase contain-
ing the RNA was collected and isopropanol was added. For
precipitation, the RNA solution was centrifuged 15min at
4∘C at high speed. The RNA pellet was then further purified
using RNeasy Mini Kit (Qiagen) according to manufacturer’s
protocol. RNA concentration was determined by measuring
absorbance at 260 nm using Nanodrop and stored at −80∘C
for further experiments.
2.4. Cell Culture. Murine cardiac fibroblasts were obtained by
outgrowth from cardiac tissue of the left ventricle from 12-
week-old male C57BL/6j mice. Therefore, the atrium as well
as the right ventricle was removed using a fine surgical scis-
sor purchased from Fine Science Tools (FST). Then, the
left ventricle was cut into small pieces, which were used
for the outgrowth of cardiac fibroblasts. Cells were cul-
tured in Dulbecco’s modified eagle medium (DMEM) con-
taining 20% fetal calf serum, 100U/mL penicillin, and
100 𝜇g/mL streptomycin (PAA). Subcultures were prepared
using Trypsin/EDTA for 3min at 37∘C. Cells were character-
ized as fibroblasts by positive immunofluorescence staining
against collagen I and negative staining for the myocyte
marker desmin and the endothelialmarkerCD31 as described
previously [24].
The cardiac muscle cell line HL-1, established from an
AT-1mouse atrial cardiomyocytes tumor lineage (kindly pro-
vided by Dr. W. C. Claycomb, Louisiana State University
Medical Center, Shreveport, Louisiana), was cultured in
gelatin/fibronectin precoated flasks with Claycomb medium
(Sigma) containing 10% fetal calf serum (PAA), 100𝜇Mnore-
pinephrine (Sigma), 0.3mM ascorbic acid (Sigma), 2mM
L-glutamine, 100U/mL penicillin, and 100 𝜇g/mL strepto-
mycin (PAA) [25]. Subcultures were prepared as described
above.
RAW264.7 cells (RAW-cells) were maintained in Dulbec-
co’s modified eagle medium (DMEM) containing 10% fetal
calf serum, 100U/mL penicillin, and 100𝜇g/mL streptomycin
(PAA). Subcultures are prepared by scraping.
All cell culture experiments were carried out at 37∘C in a
humidified atmosphere with 5% CO
2
and 95% air.
2.5. Virus Infection of Murine Cells. Cells were seeded in 24-
well plates and grown to confluence. For starving, cells were
washed once and incubated in DMEM containing 0.5% fetal
calf serum, 100U/mL penicillin, and 100𝜇g/mL streptomycin
(PAA) over night. Then, one well was used to count cell
numbers to calculate the multiplicity of infection (MOI).
Subsequently, starving mediumwas completely removed and
0.5MOI of Coxsackievirus B3 (CVB3) (Nancy strain) diluted
in DMEM without any supplements was added to infect the
cells. After 60 minutes, virus was removed and cells were
washed twice with PBS. Afterwards, cells were incubated
in starving medium for additional 5 or 23 hours. Control
cells were treated equally in the absence of virus. Cells were
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then lysed in RLT buffer (RNeasy Kit, Qiagen) contain-
ing 𝛽-mercaptoethanol as recommended in manufacturer’s
protocol. Total RNA was isolated using RNeasy Mini Kit
(Qiagen) according to manufacturer’s protocol.
2.6. Reverse Transcription and Relative Gene Expression Anal-
ysis. One 𝜇g of total RNA isolated from cardiac tissue or
250 ng total RNA isolated from murine cells was reverse
transcribed using the High Capacity Kit (Life Technologies).
For reverse transcription, samples were incubated for 2 hours
at 37∘C followed by an inactivation step of 5 minutes at 85∘C.
Finally, cDNA was diluted in water to a final concentration
of 10 ng/𝜇L for tissue samples and 1.25 ng/𝜇L for cell culture
samples.
The relative quantification of mRNA levels was carried
out on a 7900TaqMan system (AppliedBiosystems). To assess
mRNA expression of target genes, real-time PCR was per-
formed using 5𝜇L of the gene expression master mix (Life
Technologies) and 0.5 𝜇L of the gene expression assay
for TNF-𝛼 (Mm00443258 m1), IL-6 (Mm00446190 m1),
MCP-1 (Mm99999056 m1), IFN-𝛾 (Mm00801778 m1),
IFN-𝛽1 (Mm00439546 s1), CAR (Mm00438361 m1), TGF-𝛽
(Mm00441724 m1), or IL-10 (Mm00439616 m1) purchased
from Life Technologies. Each gene expression assay includes
forward and reverse primers as well as the FAM-labeled
probe. As template 1 𝜇L of cDNA was used in a final volume
of 10 𝜇L to detect mRNA expression each performed in
duplicate. Furthermore, the gene expression of CDKN1b
(Mm00438167 g1) was determined and data were normalized
to CDKN1b as an endogenous control using the formula
2
−ΔCt. The expression of CDKN1b was not affected by virus
infection.
CVB3 RNA was detected using the forward primer
CVB3 sense (5󸀠-CCCTGAATGCGGCTAATCC-3󸀠), the
reverse primer CVB3 antisense (5󸀠-ATTGTCACCATA-
AGCAGCCA-3󸀠) in a final concentration of 15 ng/𝜇L, and the
FAM-labeled CVB3-MGB-probe (5󸀠-TGCAGCGGAACCG-
3󸀠) in a final concentration of 0.25 pmol/𝜇L. To determine
the CVB3 copy numbers, a serial dilution of a plasmid,
containing the amplified CVB3 sequence, was used for the
standard curve to perform the absolute gene expression
analysis.
2.7. Quantitative RT-PCRVirus Replication. To determine the
replication for the (+) or (−) RNA strand of CVB3 we used
either the CVB3 antisense or CVB3 sense primer for reverse
transcription, respectively. Therefore, the high capacity kit
(Life Technologies) was used to transcribe 125 ng total RNA
from infected cells. Instead of the random primer we used
30 ng/𝜇L of theCVB3 strand-specific primer in a final volume
of 10 𝜇L. After reverse transcription at 37∘C for 2 hours,
followed by an inactivation step at 85∘C for 5 minutes, CVB3-
specific cDNA was further diluted to a final concentration of
1.25 ng/𝜇L. As described above, 1 𝜇L of these cDNAs was then
used to determine the strand-specific copy numbers of CVB3.
To avoid false positive results due to reverse transcription
during gene expression analysis the inactivation of the RT
enzyme has to be proven.Therefore, total RNAwas incubated
with the RT enzyme without any primer during the RT
reaction followedby the inactivation step at 85∘C.This control
was then used for gene expression analysis for CVB3 as
described and no amplification could be determined for those
samples.
2.8. Western Blot Analysis. Cells were lysed with the lysis
buffer (cell signaling) containing 1% protease as well as phos-
phatase inhibitors (sigma).The cell homogenates were mixed
with sample buffer and separated by 12% sodium dodecyl
sulfate-polyacrylamide electrophoresis gels and transferred
onto a nitrocellulose blotting membrane (BioRad Labora-
tories). Immunoblotting was performed using specific anti-
bodies against CAR (sc-15405, Santa Cruz) and alpha-actinin
(3134, cell signaling). Secondary antibodies goat anti-rabbit
IgG (Vector labartories) were used and the immunoreactive
bands were visualized due to the conjugated HRP using
super signal substrate (Thermo Fisher Scientific) in the
chemiluminescence imaging system (FUSION, Peqlab).
2.9. Statistical Analysis. Continuous variables were tested
for normal distribution using the Kolmogorov-Smirnov test.
Since not for all data normal distribution could be proved we
used Mann-Whitney 𝑈 test to compare two groups.
For comparison of multiple groups ANOVA was used
followed by Tukey’s posttest. Since all data were nonnormally
distributed, data were logarithmized resulting in normally
distributed data before ANOVA was applied. Differences
were considered statistically significant at a value of 𝑃 < 0.05.
All calculations were performed using Graph Pad Prism 5.
3. Results
3.1. Decreased LV Function after CVB3 Infection. Mice (B6)
were infected intraperitoneally with 5 × 105 pfu of CVB3
and hemodynamically characterized 7 days after infection.
As shown in Table 1 significantly decreased LV function
was determined in virus infected mice as an evidence for
myocarditis despite preserved EF.
The global cardiac function is reduced in CVB3 infected
animals compared to healthy controls. The hemodynamic
characterization revealed significantly decreased heart rate
and stroke volume resulting in impaired cardiac output.
Moreover, systolic as well as diastolic function of infected
animals was reduced compared to noninfected control mice
suggesting that the cardiac muscle cells might be negatively
affected by CVB3.
3.2. Cytokine Expression in Cardiac Tissue after CVB3 Infec-
tion. Gene expression of cytokines was analyzed in cardiac
tissue 7 days after intraperitoneal CVB3 infection. Therefore,
total RNAwas isolated, reverse transcribed, and used for gene
expression analysis.
Moreover, about 500 000 copy numbers of CVB3 were
detected per 10 ng reverse transcribed total RNA isolated
from cardiac tissue of infected B6 mice (Figure 1(b)).
We further analyzed the gene expression of the cytokines
TNF-𝛼, IL-6, MCP-1, IFN-𝛾, IFN-𝛽, and IL-10 in cardiac
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Table 1: Hemodynamic function of B6 mice 7 days after CVB3 infection.
B6-PBS treated B6-CVB3 treated 𝑃 value
Global function
Heart rate [bpm] 595 ± 13 549 ± 16 0.042
Cardiac output [𝜇L/min] 26041 ± 2297 14838 ± 1669 0.004
Stroke volume [𝜇L] 44 ± 4 27 ± 3 0.012
Stroke work [𝜇L⋅mmHg] 3468 ± 440 1697 ± 244 0.007
Ejection fraction [%] 74 ± 3 67 ± 5 0.298
Systolic function
𝑃max [mmHg] 84 ± 5 69 ± 3 0.029
dP/dtmax [mmHg/s] 9147 ± 893 6182 ± 663 0.042
𝑉es [𝜇L] 18 ± 3 14 ± 2 0.363
Diastolic function
𝑃ed [mmHg] 3.4 ± 0.5 2.3 ± 0.3 0.083
dP/dtmin [mmHg/s] −5024 ± 451 −3565 ± 300 0.019
Tau [ms] 9.4 ± 0.2 11.8 ± 0.5 0.001
PHT [ms] 5.2 ± 0.2 7.0 ± 0.5 0.007
𝑉ed [𝜇L] 60 ± 6 41 ± 3 0.019
tissue. As shown in Figures 1(c)–1(e), the expression of the
proinflammatory cytokines TNF-𝛼 (7-fold), IL-6 (9-fold),
and MCP-1 (15-fold) was significantly increased in infected
mice compared to healthy controls. As suggested, 7 days after
CVB3 infection the antiviral cytokines IFN-𝛽 and IFN-𝛾were
expressed in cardiac tissue but were not detected in healthy
controls (Figures 1(f) and 1(g)). Furthermore, gene expression
of the anti-inflammatory cytokine IL-10 was also significantly
increased (12-fold) in the tissue of infectedmice (Figure 1(h)).
3.3. CVB3 Leads to Severe Cell Infiltration into Cardiac Tissue.
Cryosections of cardiac tissue were examined to assess the
invasion of inflammatory cells into cardiac tissue of infected
mice using hematoxylin and eosin-staining. As shown in
Figure 1(a), cardiac tissue of infected mice demonstrated a
large number of invaded inflammatory cells 7 days after infec-
tion. Different cell types in addition to the resident cardiac
cells such as fibroblasts and cardiomyocytes are present in
cardiac tissue. The detected increased gene expression of
proinflammatory, antiviral, and anti-inflammatory cytokines
in the inflamed cardiac tissue as shown in Figure 1 can
originate from the entered inflammatory or from resident
cardiac cells.
3.4. Cytokine Expression in Different Murine Cell Types after
CVB3 Infection. To examine the cell specific response to virus
infection, we infected murine cardiac fibroblasts, murine
cardiomyocytes (HL-1 cells), andmurinemacrophages (RAW
cells) with 0.5MOI of CVB3. After 1 hour of infection,
cells were washed and incubated for further 5 or 23 hours
regarding the experimental design and time.
In Figure 2, the gene expression was plotted as x-fold to
the house keeping gene CDKN1b to compare the absolute
mRNA expression of the analyzed cytokines between the
different murine cell types. The proinflammatory cytokines
TNF-𝛼, IL-6, and MCP-1 are well expressed by cardiac fibro-
blasts. The gene expression was increased caused by CVB3
infection (TNF-𝛼 3-fold, IL-6 3-fold, and MCP-1 5-fold) as
it was already detected in virus infected cardiac tissue. Gene
expression of these three proinflammatory cytokines is hardly
detectable in cardiomyocytes. Only a weak gene expression
of IL-6 was measured. Furthermore, in macrophages only
TNF-𝛼was highly expressed compared to cardiac fibroblasts,
but the gene expression was not altered by CVB3 infection.
Nevertheless, the presence and accumulation ofmacrophages
in inflamed cardiac tissue lead to increased TNF-𝛼 gene
expression in tissue samples as shown earlier in Figure 1.
Moreover, the antiviral cytokine IFN-𝛾 could not be
detected in the investigated cell types. Hence, none of the
here investigated cells are responsible for the virus-induced
IFN-𝛾 expression in cardiac tissue. In contrast, the antiviral
cytokine IFN-𝛽was only detectable in cardiac fibroblasts and
was significantly increased 24 hours after CVB3 infection
(5-fold) as already shown in the cardiac tissue of infected
mice. The gene expression of the anti-inflammatory cytokine
IL-10 was examined in these murine cell types. Interestingly,
no expression was detectable in the here investigated cells.
3.5. Virus Load and Virus Replication in Different Murine
Cell Types. To determine the virus load in cells infected
with 0.5MOI of CVB3, total RNA was reverse transcribed
using random primer and copy numbers were assessed using
TaqMan analysis. As shown in Figure 3(a) murine cardiac
fibroblasts reveal more than 30 000 CVB3 copies per 1.25 ng
transcribed RNA6 hours after infection. A significantly lower
virus load with approximately 10 000 CVB3 copies was mea-
sured in murine cardiomyocytes. Therefore, a clear infection
was determined. In contrast, in murine macrophages the
detectable virus load was lower than 100 CVB3 copies 6 hours
after infection.This result leads to the suggestion that cardiac
fibroblasts are more efficiently infected than cardiomyocytes.



































































































































































































Figure 1: Increased cardiac inflammation in mice 7 days after CVB3 infection. (a) Hematoxylin/eosin staining of cardiac tissue from CVB3
infected B6 mice revealed a clear number of invaded inflammatory cells. (b) Virus load in cardiac tissue 7 days after CVB3 infection. ((c)–
(h)) Gene expression analyses of various cytokines in cardiac tissue of healthy (white bar) and CVB3 infected (grey bar) B6 mice. Data were
plotted as mean ± SEM as x-fold to the house keeping gene CDKN1b. ∗Significantly different versus noninfected mice (control); ∗∗𝑃 < 0.01;
∗∗∗
𝑃 < 0.001; n.d.: not detectable.
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Figure 2: Gene expression of various cytokines after CVB3 infection of different murine cell types. Murine cardiac fibroblasts, murine
cardiomyocytes (HL-1 cell line), and murine macrophages (RAW cell line) were infected with 0.5MIO of CVB3. Gene expression of various
cytokines was assessed 6 and 24 hours after CVB3 infection. To compare the absolute gene expression between the different cell types gene
expression is plotted as mean ± SEM as x-fold to the house keeping gene CDKN1b. ∗Significantly different versus respective noninfected cells
(control); ∗𝑃 < 0.05; ∗∗𝑃 < 0.01; ∗∗∗𝑃 < 0.001; n.d.: not detectable.
Furthermore, we determined the gene expression of
one of the cellular receptors of CVB3, the Coxsackievirus-
adenovirus receptor (CAR). As shown in Figure 3(c), cardiac
fibroblasts revealed a similar expression of CAR as deter-
mined in cardiomyocytes. This gene expression was nearly
2 times increased in cardiac fibroblasts but not altered in
cardiomyocytes 24 hours after infection. In contrast, no
CAR gene expression was detectable inmurinemacrophages,
which was confirmed by western blot analysis (Figure 3(d)).
To investigate the virus replication in different murine
cell types, CVB3 copy number 24 hours after infection was
normalized by the detected copy number 6 hours after
infection. We plotted the ratio of CVB3 copy numbers 24
hours/6 hours. This was done to minimize the possible
influence due to differences in the viral infection efficiency
seen in Figure 3(a). This ratio shows the amount of viral
replications between 6 and 24 hours. As shown in Figure 3(b),
in cardiac fibroblasts CVB3 copy number was nearly 200
times increased after 24 hours compared to the determined
copy number 6 hours after infection. In cardiomyocytes
CVB3 copy numbers after 24 hours were 65-fold increased
compared to CVB3 copy numbers after 6 hours.
In macrophages nearly the same amount of CVB3 copies
was determined after 24 and after 6 hours. Thus, cardiac


















































































































Figure 3: Viral infection and replication in different murine cell types. (a) CVB3 virus load in murine cardiac fibroblasts, murine
cardiomyocytes, or murine macrophages was determined 6 hours after infection with 0.5MOI CVB3. Here, cDNA transcribed with random
primer was used. (b) Virus replication was determined by the ratio between detected CVB3 copy numbers 24 hours after infection and
copy numbers 6 hours after infection. Copy numbers were determined using cDNA reverse transcribed with random primer. Ratios higher
than one indicate virus replication. (c) Gene expression of Coxsackievirus-adenovirus receptor (CAR) was examined in cardiac fibroblasts,
cardiomyocytes, and macrophages 24 hours after CVB3 infection and compared to the expression of noninfected control cells. (d) Western
blot analysis revealed that CAR protein is detected in cardiac fibroblasts and is absent in macrophages (RAW cells). As endogenous control,
𝛼-actinin was performed. Data are plotted as mean ± SEM and ratios are plotted as box plots with median. ((a), (b)) ∗Significantly different
versus cardiac fibroblasts; ∗𝑃 < 0.05; ∗∗∗𝑃 < 0.001 §significantly different versus cardiomyocytes; §§§𝑃 < 0.001; (c) ∗significantly different
versus respective noninfected control; ∗𝑃 < 0.05; n.d.: not detectable.
fibroblasts as well as cardiomyocytes replicate CVB3 in con-
trast to macrophages, where no changes could be observed.
According to this result, neither virus replication nor virus
clearance was determined in macrophages.
Furthermore, the amount of isolated total RNA from
macrophages does not differ between sampleswith orwithout
virus, suggesting that no cell lysis due to the cytolytic
cycle of the virus has occurred within 24 hours after
infection (Figure 5(d)). Therefore, it can be suggested that
the macrophages are not killed by CVB3 within 24 hours.
Interestingly, a decreasing amount of isolated total RNA was
detected with increasing MOI of CVB3 in cardiac fibroblasts
after 24 hours. Furthermore, decreased amounts of total
RNA were also detected in infected HL-1 cells. Those results
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Figure 4: CVB3 copy numbers of the viral RNA genome (+) strand as well as the intermediate (−) RNA strand for virus replication. The
copy number of the viral RNA genome (+) strand and the copy number of the intermediate (−) strand needed for virus replication were
determined using strand-specific primers for reverse transcription followed by TaqMan analysis. (a) Copy numbers of (+) strand (viral RNA
genome) of CVB3 6 hours and 24 hours after infection of murine cardiac fibroblasts, murine cardiomyocytes (HL-1 cell line), and murine
macrophages (RAW cell line). (b) Copy numbers of (−) strand (intermediate RNA strand for virus replication) of CVB3 6 hours and 24 hours
after infection of murine cardiac fibroblasts, murine cardiomyocytes (HL-1 cell line), and murine macrophages (RAW cell line). ((c), (d))
Ratio between copy numbers 24 hours compared to copy numbers 6 hours after CVB3 infection for (c) (+) strand and (d) (−) strand. Ratios
higher than one demonstrate virus replication. ((a), (b)) ∗Significantly different versus copy numbers 6 hours after infection; ∗𝑃 < 0.05;
∗∗
𝑃 < 0.01. Data are plotted as mean ± SEM. ((c), (d)) ∗Significantly different versus cardiac fibroblasts; ∗∗∗𝑃 < 0.001 §significantly different
versus cardiomyocytes; §§§𝑃 < 0.001. Ratios are plotted as box plots with median.
suggest that in the culture of cardiac fibroblasts as well as
cardiomyocytes cell lysis occurs due to the cytolytic cycle of
the virus within 24 hours after infection.
3.6. Copy Numbers of Viral Genome and Intermediate Strand
for Virus Replication. Since it is not clear if macrophages
are really infected by CVB3, additional experiments were
performed. The detected CVB3 copies can also correspond
to incompletely removed virus particles instead of virus
RNA within the cells due to a reliable virus infection. The
intermediate strand, which is necessary for virus replication,
can only be detected in infected cells and cannot correspond
to the incompletely removed virus particles.
Therefore, the total RNA isolated from infected cells was
used to identify the copy number of the (+) strand which
represents the number of RNAvirus genome of CVB3 and the
Mediators of Inflammation 9
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Figure 5: Virus clearance or persistence in macrophages infected with high or low MOI of CVB3. Murine macrophages (RAW cells) were
infected with 5MOI or 0.5MOI of CVB3.The copy number of the viral RNA genome (+) strand and the copy number of the intermediate (−)
strand needed for virus replication were determined using specific primers for reverse transcription followed by TaqMan analysis. (a) Copy
numbers of both CVB3 strands using different MOI 6 hours and 24 hours after infection. (b) Ratio between copy numbers after 24 hours
after infection compared to 6 hours after CVB3 infection. Ratios lower than 1 show virus elimination. (c) To determine gene expression of
macrophages infected with 5 or 0.5MOI of CVB3 total RNA was reverse transcribed using random primer and gene expression of TNF-𝛼,
MCP-1, and TGF-𝛽 was determined 6 hours after infection. (d) 24 hours after infection with CVB3 cells were washed to remove cell debris
and then total RNA was isolated from the remaining cells. The isolated amount of total RNA is plotted and revealed a decrease due to virus
infection followed by cell lysis in cardiac fibroblasts and cardiomyocytes but not in macrophages. (a) ∗Significantly different versus copy
numbers 6 hours after infection; ∗∗𝑃 < 0.01. Data are plotted as mean ± SEM. (b) ∗Significantly different versus 5MOI; ∗∗𝑃 < 0.01. Ratios
are plotted as box plots with median. (c) ∗Significantly different versus noninfected control, ∗𝑃 < 0.05; ∗∗𝑃 < 0.01; ∗∗∗𝑃 < 0.001. Data are
plotted as mean ± SEM.
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(−) strand which is synthesized in infected cells as a template
to produce the (+) strand for new virus particles. Therefore,
the (−) strand is an intermediate for virus replication. As
shown earlier in Figure 3, macrophages were hardly infected
by CVB3 which is further strengthened by the fact that
no gene expression of CAR, known as CVB3 receptor, was
determined in macrophages.
Therefore, CVB3 antisense primer was used as a CVB3
(+) strand-specific primer to transcribe this specific RNA
strand into cDNA (+). Accordingly, CVB3 sense primer
was used as a specific primer to transcribe the CVB3 (−)
strand into cDNA (−). To avoid false positive results the
enzyme reverse transcriptase has to be inactivated prior to
the gene expression analysis [26]. After inactivation both
types of cDNAwere used for TaqMan analysis to evaluate the
specific copy numbers for each strand separately. As shown
in Figures 4(a) and 4(b), in cardiac fibroblasts (black bars)
as well as in cardiomyocytes (red bars) the copy number
of both strands was significantly increased 24 hours after
infection compared to copy numbers 6 hours after infection.
Contrarily, in macrophages the copy numbers do not differ
remarkably between 6 hours and 24 hours after infection.
Since macrophages display less than 100 copies, it is
unclear if these detected CVB3 copies correspond rather to
the incompletely removed virus particles than to those virus
particles which have infected macrophages. An evidence for
infectionwould be a detectable expression of the intermediate
(−) strand of CVB3. As shown in Figure 4(b), the replication
of CVB3was proven by detection of the (−) strand of CVB3 in
all three cell types. Accordingly, macrophages were infected
by CVB3 even if no gene expression of CAR was detectable.
To compare the replication of each CVB3 RNA strand in
the different cell types, in Figures 4(c) and 4(d) we plotted
the ratio of CVB3 copy numbers 24 hours/6 hours. This was
done to minimize the possible influence due to differences in
the viral infection efficiency seen in Figure 4(a). Then, viral
replication between 6 and 24 hours can clearly be identified.
In cardiac fibroblasts the (+) and the (−) strands of CVB3
were dramatically increased between 6 and 24 hours ((+)
strand > 100-fold, (−) strand > 300-fold). This is signifi-
cantly different from the detected ratio in cardiomyocytes
and macrophages. In cardiomyocytes the replication of the
intermediate CVB3 (−) strand is only slightly increased (4-
fold) but is enough to clearly replicate the CVB3 (+) strand
(14-fold) between 6 and 24 hours. Inmacrophages, only a very
weak replication was detectable for the (+) strand (1.7-fold)
and the (−) strand (1.8-fold).
3.7. Macrophages Cannot Clear Virus Completely. Since ma-
crophages belong to the innate immune system virus eli-
mination was expected. All previous experiments were car-
ried out with a 0.5MOI of CVB3. In Figure 5, macrophages
were also infected with 5MOI of CVB3 and again the isolated
total RNA was reverse transcribed with CVB3 (+) and (−)
strand specific primers. These resulted cDNAs were further
used for TaqMan analysis to determine the strand specific
copy numbers.
After infectionwith 5MOI of CVB3,macrophages exhibit
higher copy numbers 6 hours after infection for (+) and (−)
strands compared to macrophages infected with 0.5MOI of
CVB3 as shown in Figure 5(a). 24 hours after CVB3 infection
with 5MOI the copy numbers for (+) as well as for (−)
strands are significantly decreased ((+) strand −3.6-fold, (−)
strand −4.5-fold) nearly to the level of CVB3 copy numbers
detected 24 hours after infection with 0.5MOI, whereas no
significant changeswere determined inmacrophages infected
with 0.5MOI of CVB3 between 6 hours and 24 hours after
infection.
To determine if virus replication or virus clearance occurs
in macrophages after CVB3 infection, the ratio of CVB3
copy numbers 24 hours/6 hours is plotted in Figure 5(b).
It is clearly shown for the (+) and for the (−) strands that
macrophages are able to eliminate CVB3 at 5MOI, but no
clear virus replication or elimination is documented for
0.5MOI of CVB3.
Furthermore, the gene expression of the proinflammatory
cytokine TNF-𝛼 is increased (6-fold) in macrophages
infected with 5MOI of CVB3 6 hours after infection, in
contrast to macrophages infected with 0.5MOI, in which no
alteration was measured. Similar results were found for the
chemokine MCP-1. The gene expression remains unchanged
after infection with 0.5MOI of CVB3 but increases after
infection with 5MOI (28-fold). However, expression of
the profibrotic and anti-inflammatory cytokine TGF-𝛽 is
increased by 5MOI CVB3 (4.7-fold) but remains unchanged
after CVB3 infection with 0.5MOI.
4. Discussion
In this study, we elucidate a cell type specific immune
response to CVB3 using murine cardiac fibroblasts, car-
diomyocytes, and macrophages. Additionally, we document
differences in virus infection, virus replication, or elimination
between these cell types. Cardiac fibroblasts are infected
with high efficiency by CVB3 and resulted in a much higher
virus replication compared to cardiomyocytes. Interestingly,
macrophages were infected by CVB3 with a very low effi-
ciency but revealed virus degradation only when infected
with high virus concentrations. However, no complete virus
clearance by macrophages was observed.
4.1. Inflammation during Viral Myocarditis. First, we ana-
lyzed the cardiac tissue from B6 mice, which were peri-
toneally infected with CVB3, or control animals, which
were PBS treated. Seven days after infection, the cardiac
tissue from infected animals clearly exposes inflammatory
cellular infiltrates, which conforms to the general definition
of myocarditis [1, 3, 6]. Moreover, the cardiac tissue of
infected animals clearly exhibits copy numbers of CVB3.
Viral myocarditis can be divided into 3 phases. The
first acute phase is when susceptibility to viral infection
is determined and direct consequences of virus-induced
cytotoxicity in the absence of inflammatory cells can be seen
within the first 3 days after infection [3, 18]. The next phase,
the subacute phase, is defined by active replication of virus
occurring in themyocardium (days 4–14) and the firstwave of
infiltrating cells [18]. Finally, during the chronic phase of viral
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myocarditis virus replication has ceased but viral genome
persists in the myocardium. Furthermore, remodeling takes
place after myocardial damage due to virus infection and
inflammation during phases 1 and 2 [3, 18]. Our data, 7 days
after CVB3 infection, are consistent with the subacute phase
of viral myocarditis.
Inflammatory cells already infiltrated the cardiac tis-
sue and various cytokines, including proinflammatory and
antiviral cytokines, are expressed. In this study, we showed
increased expression levels of proinflammatory cytokines
(TNF-𝛼, IL-6, and MCP-1) as well as antiviral cytokines
(IFN-𝛽 and IFN-𝛾) and an anti-inflammatory cytokine
(IL-10) due to viral myocarditis in cardiac tissue. Those
cytokines play an important role to regulate the increasing
inflammation due to virus infection. In transgenic mice
overexpressing IL-6 in cardiac tissue, an association with
elevated basal inflammation was shown [27]. Interestingly,
anti-inflammatory treatments with a soluble TNF receptor
or with a neutralizing antibody against chemokines can
reduce cardiac inflammation and prevent cardiac damage in
experimental models [11, 28] but not in randomized clinical
trials [29]. On the other hand, antiviral treatment using
IFN-𝛽 or IFN-𝛼 improves cardiac function in patients with
persistent virus infection [30, 31] which is in line with the
finding that an IFN-𝛽 neutralizing antibody increased virus
replication in cardiomyocytes [10].
Those proinflammatory or antiviral cytokines are present
in the cardiac tissue and it is not clearwhich cell type ismainly
responsible for a specific cytokine elevation.Here, we infected
three different cell types in vitro with 0.5MOI of CVB3 and
analyzed the cell type specific cytokine expression.Therefore,
we used murine primary cardiac fibroblasts, the murine car-
diomyocyte cell line HL-1, and the murine macrophage cell
line RAW. Fibroblasts are found throughout the cardiac tissue
surrounding cardiomyocytes, and they present the most
numerous cell types in the heart. Macrophages constitute a
major part of the innate immune system. Hence, they are at
the front line of defense against fungi, bacteria, and viruses
[15]. Interestingly, macrophages reside in the healthy cardiac
tissue, although they are not as frequent as cardiomyocytes
or fibroblasts. But during diseases their number is increased
[16].
The expression of proinflammatory cytokines (TNF-𝛼,
IL-6, and MCP-1) was increased in cardiac fibroblasts due to
CVB3 infection. In cardiomyocytes a very weak expression
of IL-6 and no detectable expression of TNF-𝛼 and MCP-1
were determined. Interestingly, the expression of IL-6 was
decreased in cardiomyocytes 6 hours after viral infection.
Macrophages express TNF-𝛼 and MCP-1, whereas MCP-1
expression was slightly increased due to CVB3 infection and
TNF-𝛼 expression remains unchanged. If macrophages were
infected with a 10-fold higher amount of CVB3 (5MOI)
gene expression of the proinflammatory cytokines TNF-𝛼
and MCP-1 are then upregulated after 6 hours. Moreover,
the chemokine MCP-1 is expressed nearly 100-fold higher in
cardiac fibroblasts than in macrophages but virus leads to
increased expression of MCP-1 in both cell types.
The antiviral cytokine IFN-𝛾 and anti-inflammatory
cytokine IL-10 are mainly related to T-cells. No expression
of IFN-𝛾 and IL-10 was detected in the here investigated cell
types [32], whereas IFN-𝛽 is well expressed in cardiac fibro-
blasts. The expression of IFN-𝛽 is related to Toll-like recep-
tors, which are known to recognize nucleic acids such as viral
RNA. This mechanism also belongs to the innate immune
system. It was recently shown that high IFN-𝛽 expression
levels diminished virus replication in cardiomyocytes [10].
4.2. Virus Infection and Replication after CVB3 Infection. The
coxsackievirus and adenovirus receptor (CAR)was identified
as the cellular receptor for CVB3 [33–35]. Murine cardiac
fibroblasts, cardiomyocytes, and macrophages were tested
for the gene expression of CAR. The cardiac fibroblasts
revealed a high expression of CAR similar to cardiomyocytes,
which was further increased during 24 hours after virus
infection. In cardiomyocytes, CAR expression remains at the
same level. Furthermore, it is reported that CVB3 infected
cardiomyocytes revealed a downregulation of CAR within 3
passages [21]. Formurinemacrophages no gene expression of
CAR could be determined but very low infection by CVB3
was still detectable. Further no CAR protein was detected
in macrophages. This suggests that CAR is not expressed
or lower expressed than the detection level, which would
be consistent with the determined low infection. Another
reason might also be that CVB3 particles enter the cells after
attaching to another receptor, which is also reported as CVB3
receptor, the decay-accelerating factor (DAF)/CD55 [36]. In
another study on human cardiac cells an internalization
of CVB3 is reported in the presence of CD55 and CAR-
blocking monoclonal antibodies. Furthermore, they found
using immunoprecipitation that CVB3 binds at least five
additional cellular receptors, distinct from CAR and CD55,
on the surface of human cardiac cells [37]. This suggests that
CVB3 appears to employ multiple receptors to internalize in
cardiac cells.
After entering the cells, virus typically starts replication
[38, 39]. In general, virus replication consists of two steps.
First, a complementary negative strand from virion RNA is
synthesized, which then serves as a template for the synthesis
of a large amount of progeny positive-strand RNAs [40, 41].
Since the genome of CVB3 consists of a (+) strand RNA,
a (−) strand RNA has to be synthesized as an intermediate
for virus replication. Murine cardiac fibroblasts as well as
cardiomyocytes reveal a severe infection of CVB3 in contrast
to macrophages, in which less than 100 copies were detected.
It was unclear if these detected CVB3 copies correspond to
incompletely removed virus particles or to virus particles
within the cells due to a reliable virus infection. Here, the
evidence, that the macrophages are infected by virus, is
provided by the detection of the intermediate (−) strand of
CVB3 [40].
Furthermore, cardiac fibroblasts reveal a tremendous
virus replication for the progeny (+) strand as well as for
the intermediate (−) strand. In fibroblasts both strands were
highly amplified between 6 hours and 24 hours after CVB3
infection as seen in Figure 6. The (+) strand was 132-fold
increased between 6 and 24 hours (83 × 103 → 11 ×
106 copies). In contrast, in cardiomyocytes less CVB3 copy
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Cardiac fibroblast Cardiomyocyte Macrophage Macrophage
Replication Replication
(+) 83 × 103 → 11 × 106
(−) 18 × 103 → 2.1 × 106
(+) 7.5 × 103 → 107 × 103
(−) 4.3 × 103 → 19 × 103
Weak replication
(+) 17 → 32
(−) 5 → 9
Elimination
(+) 258 → 71
(−) 56 → 12
5 MOI0.5 MOI0.5 MOI0.5 MOI
−+ −+ −+ −+
Figure 6: Comparison of CVB3 replication in different cell types. Due to viral infection cardiac fibroblasts revealed 132-fold increase (83 ×
103 → 11 × 106 copies) of the viral (+) RNA strand between 6 and 24 hours leading to a severe virus replication, whereas in cardiomyocytes
14-fold increase (7.5 × 103 → 107 × 103 copies) of the viral (+) RNA strand was measured. In macrophages, low virus concentration leads to
weak virus replication (17 → 32 copies). High virus concentration leads to virus elimination but not to complete virus clearance (258 → 71
copies). The copy numbers of both CVB3 strands 6 hours and 24 hours after infection are given (6 h → 24 h).
numbers were detected and the amount of the intermediate
(−) strands was hardly increased between 6 hours and 24
hours after infection. But this amountwas obviously sufficient
to produce an increased amount of the progeny (+) strand
RNA leading to a 14-fold increase of the (+) strand (7.5 ×
103 → 107 × 103 copies).
Since macrophages are part of the innate immune system
they are often the first to identify and engulf invading
pathogens [15]. Furthermore, they are responsible for antigen
presentation for T-cells. A similar function is also reported
for dendritic cells. They identify, engulf pathogens, and
finally present their parts as antigens [17]. Here, we used the
macrophage cell line RAW264.7. An infection with CVB3
was proven for this specific cell type, since the positive as
well as the negative RNA strand of CVB3 was determined.
Interestingly, Weinzierl et al. recently documented this in
dendritic cells [17]. There, CD11c+ dendritic cells derived
from C57BL/6 were able to completely eliminate the negative
RNA strand of CVB3 within 8 days after infection. In our
cell culture experiments, macrophages infected with 5MOI
reduce the number of (+) as well as (−) strands but no
alteration within 24 hours was measured in macrophages
infected with 0.5MOI.This might be an explanation for virus
persistence in the cardiac tissue, since macrophages can only
reduce, but not completely clear, the infected tissue from
CVB3.
In summary, cardiac fibroblasts as well as cardiomy-
ocytes are target cells for CVB3 infection. Both cardiac cell
types replicate the intermediate (−) strand and the progeny
(+) strand RNA whereas no reliable increasing virus RNA
was detected in macrophages. At higher virus concentra-
tions, macrophages eliminate CVB3 but no complete virus
clearance could be observed suggesting a persistent viral
infection. Cardiac fibroblasts aggravate CVB3-induced viral
myocarditis by exacerbated virus replication compared to
cardiomyocytes. On the other hand, they initiate cardiac
inflammation by upregulating the gene expression of proin-
flammatory cytokines such as TNF-𝛼, IL-6, and MCP-1 as
well as antiviral IFN-𝛽 which was not observed in cardiomy-
ocytes infected by CVB3. Future studies have to elucidate
whether these in vitro changes using different cell types are
important in vivo investigating murine models as well as
human patients with myocarditis.
In conclusion, we suggest that cardiac fibroblasts play an
important part in the pathology of CVB3-induced myocardi-
tis. Those results should trigger further research aiming
cardiac fibroblasts as another important contributor of virus
replication which can exacerbate myocarditis.
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